Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk

被引:32
|
作者
Andersson, Patiyan [1 ]
Varenhorst, Eberhard
Soderkvist, Peter
机构
[1] Linkoping Univ, Fac Hlth Sci, Dept Biomed & Surg, Div Cell Biol, SE-58185 Linkoping, Sweden
[2] Linkoping Univ, Fac Hlth Sci, Dept Biomed & Surg, Div Urol, SE-58185 Linkoping, Sweden
关键词
androgen receptor; vitamin D receptor; prostate cancer; CAG repeat;
D O I
10.1016/j.ejca.2006.06.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We study the CAG repeat region in exon 1 of the androgen receptor (AR) and the TaqI polymorphism in exon 9 of the vitamin D receptor (VDR) and the association with prostate cancer. 137 incidentally discovered, histologically verified prostate cancers were analysed for CAG repeat length in AR and genotype at the TaqI site of the VDR. 124 control subjects were analysed to determine the CAG repeat length and TaqI genotype determined for 176 control subjects. An unpaired t-test shows that the mean CAG repeat length was significantly (p < 0.001) shorter among cases (20.1 repeats) compared with controls (22.5 repeats). Dividing the prostate cohort and controls into tertiles (<= 19, 20-22, >= 23 repeats) shows that short repeats are significantly more common among cases (odds ratio (OR) 4.45, p = 0.00003). Genotype frequencies for the TaqI polymorphism reveals no significant differences between cases and controls. We conclude that men with a short CAG repeat in the androgen receptor gene have an increased risk of developing prostate cancer. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2833 / 2837
页数:5
相关论文
共 50 条
  • [31] Effect modifiers of vitamin D receptor common polymorphisms on prostate cancer risk
    Batai, Ken
    Murphy, Adam B.
    Shah, Ebony
    Kittles, Rick A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
  • [32] Vitamin D receptor TaqI polymorphisms and risk of developing prostate cancer.
    Panczyk, E
    Jacobs, ET
    Reid, ME
    Marshall, JR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S90 - S90
  • [33] Vitamin D receptor TaqI polymorphisms and risk of developing prostate cancer.
    Panczyk, E
    Jacobs, ET
    Reid, ME
    Marshall, JR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (02) : S386 - S386
  • [34] Androgen receptor signaling and vitamin D receptor action in prostate cancer cells
    Murthy, S
    Agoulnik, IU
    Weigel, NL
    PROSTATE, 2005, 64 (04): : 362 - 372
  • [35] VITAMIN D RECEPTOR GENE POLYMORPHISMS AND RISK OF PREECLAMPSIA
    Wei, S. Q.
    Julien, P.
    Luo, Z. C.
    Audibert, F.
    Fraser, W.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S79 - S79
  • [36] Vitamin D receptor gene polymorphisms and the risk of myopia
    Guggenheim, Jeremy
    Northstone, Kate
    McMahon, George
    St Pourcain, Beate
    Williams, Cathy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [37] Genetic variants in the vitamin D receptor gene and prostate cancer risk
    Hayes, VM
    Severi, G
    Padilla, EJD
    Eggleton, SA
    Southey, MC
    Sutherland, RL
    Hopper, JL
    Giles, GG
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 997 - 999
  • [38] Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer
    Slattery, ML
    Sweeney, C
    Murtaugh, M
    Ma, KN
    Caan, BJ
    Potter, JD
    Wolff, R
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) : 3140 - 3146
  • [39] Vitamin D receptor gene polymorphisms in breast cancer
    Buyru, N
    Tezol, A
    Yosunkaya-Fenerci, E
    Dalay, N
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2003, 35 (06): : 550 - 555
  • [40] Vitamin D receptor gene polymorphisms in breast cancer
    Nur Buyru
    Ayda Tezol
    Elif Yosunkaya-Fenerci
    Nejat Dalay
    Experimental & Molecular Medicine, 2003, 35 : 550 - 555